Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for InfuSystems Holdings, Inc. (INFU : AMEX)
 
 • Company Description   
InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management.

Number of Employees: 514

 
 • Price / Volume Information   
Yesterday's Closing Price: $6.19 Daily Weekly Monthly
20 Day Moving Average: 273,619 shares
Shares Outstanding: 21.02 (millions)
Market Capitalization: $130.09 (millions)
Beta: 1.81
52 Week High: $9.97
52 Week Low: $4.61
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 1.48% -2.32%
12 Week 26.07% 6.04%
Year To Date -26.75% -31.40%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3851 West Hamlin Road
-
Rochester Hills,MI 48309
USA
ph: 248-291-1210
fax: 800-455-4338
None http://www.infusystem.com
 
 • General Corporate Information   
Officers
Richard DiIorio - Chief Executive Officer and Director
Scott Shuda - Chairman
Carrie Lachance - President and Chief Operating Officer
Barry Steele - Chief Financial Officer
Kenneth Eichenbaum - Director

Peer Information
InfuSystems Holdings, Inc. (BJCT)
InfuSystems Holdings, Inc. (CADMQ)
InfuSystems Holdings, Inc. (APNO)
InfuSystems Holdings, Inc. (UPDC)
InfuSystems Holdings, Inc. (IMTIQ)
InfuSystems Holdings, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 45685K102
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
Share - Related Items
Shares Outstanding: 21.02
Most Recent Split Date: (:1)
Beta: 1.81
Market Capitalization: $130.09 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.02 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.06 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 103.17
Trailing 12 Months: 44.21
PEG Ratio: -
Price Ratios
Price/Book: 2.36
Price/Cash Flow: 8.82
Price / Sales: 0.95
EPS Growth
vs. Year Ago Period: 80.00%
vs. Previous Quarter: -125.00%
Sales Growth
vs. Year Ago Period: 8.50%
vs. Previous Quarter: 2.56%
ROE
06/30/25 - -
03/31/25 - 5.76
12/31/24 - 4.29
ROA
06/30/25 - -
03/31/25 - 3.03
12/31/24 - 2.22
Current Ratio
06/30/25 - -
03/31/25 - 2.21
12/31/24 - 1.82
Quick Ratio
06/30/25 - -
03/31/25 - 1.83
12/31/24 - 1.45
Operating Margin
06/30/25 - -
03/31/25 - 2.32
12/31/24 - 1.74
Net Margin
06/30/25 - -
03/31/25 - 2.32
12/31/24 - 1.74
Pre-Tax Margin
06/30/25 - -
03/31/25 - 4.80
12/31/24 - 3.75
Book Value
06/30/25 - -
03/31/25 - 2.62
12/31/24 - 2.71
Inventory Turnover
06/30/25 - -
03/31/25 - 9.86
12/31/24 - 9.80
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.52
12/31/24 - 0.41
Debt-to-Capital
06/30/25 - -
03/31/25 - 34.23
12/31/24 - 29.32
 

Powered by Zacks Investment Research ©